Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis
This study is not yet open for participant recruitment.
Study NCT00532519   Information provided by Hadassah Medical Organization
First Received: September 19, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prurigo Nodularis
Additional conditions recognized in this trial
Neurodermatitis
Prurigo
More general conditions related to this trial
Dermatitis
Skin Diseases
Skin Diseases, Eczematous
Interventions listed in this trial
citalopram (cipralex)
Additional drug interventions recognized in this trial
Citalopram
Dexetimide
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiparkinson Agents
Autonomic Agents
Central Nervous System Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Therapeutic Uses
Sponsors listed in this trial
Hadassah Medical Organization


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services